Skip to main content

Advertisement

We’d like to understand how you use our websites in order to improve them. Register your interest.

Recurrent lumbar-origin osteoblastoma treated with multiple surgery and carbon ion radiotherapy: a case report

Abstract

Background

Although osteoblastoma is an uncommon benign bone tumor, it sometimes behaves in a locally aggressive fashion. We herein report a case of recurrent lumbar spine osteoblastoma that was treated by repeated surgery and carbon ion radiotherapy.

Case presentation

A 13-year-old Japanese girl presented with left side lumbar pain. Computed tomography and magnetic resonance imaging of the lumbar spine demonstrated a tumorous lesion in the left side pedicle of L4. Although gross total resection of the mass, including the nidus, was performed in the initial surgery, recurrence was observed repeatedly in the short term and the pathological diagnosis of all of the resected tumors was conventional osteoblastoma. We finally performed carbon ion radiotherapy after the patient’s 3rd palliative operation, and achieved a good outcome. No further recurrence has been observed in 10 years of follow-up.

Conclusion

We performed carbon ion radiotherapy for a case of recurrent spinal osteoblastoma and achieved a good outcome without recurrence at 10 years after carbon ion radiotherapy treatment. To the best of our knowledge, this is the first case of osteoblastoma that was treated with carbon ion radiotherapy after multiple surgeries.

Peer Review reports

Background

Osteoblastoma (OB) is an uncommon benign bone tumor that accounts for 1% of all primary bone tumors, and approximately 30–40% of all OBs occur on the spine [1, 2]. It is well known that OBs tend to behave more aggressively than other benign bone tumors [3]. Although total resection of the tumor is now the main treatment for cases of symptomatic spinal OB, it is often difficult to complete total resection because of adhesion between the tumor and the surrounding tissues, such as nerve roots or the vertebral artery [1].

Adjuvant chemotherapy and radiotherapy can be considered if OB exhibits an aggressive nature, such as recurrence or malignant change. Furthermore, it has been reported that carbon ion radiotherapy (CIRT) has a cell-killing effect that is 2–3 times greater than X-ray radiotherapy, and also has curative potential in cases involving X-ray-resistant tumors [4, 5]. However, there have been no reports on the use of adjuvant CIRT in the treatment of recurrent lumbar spine OB. We herein report a case of recurrent lumbar spine OB that was treated by repeated surgery and CIRT.

Case presentation

The patient was a 13-year-old Japanese girl who presented with left side lumbar pain that had persisted for 7 months. She also complained of pain and torpor of the left lower limb for 2 weeks prior to admission for the initial surgery. A neurological examination revealed that the muscle strength of the left side iliopsoas, quadriceps femoris, and tibial anterior muscles was 4/5, 4/5, and 5/5, respectively.

An X-ray examination revealed no remarkable space occupying lesions. Computed tomography (CT) showed an osteolytic lesion on the left side of the L4 pedicle (Fig. 1a). Magnetic resonance imaging (MRI) showed a tumorous lesion extending from the L4 pedicle to the epidural space (Fig. 1b). CT-guided biopsy was performed. Histologically, the tumor showed typical features of osteoblastoma, which was composed of woven bone trabeculae rimmed with a single layer of osteoblasts. There was no marked nuclear pleomorphism or mitotic activity.

Fig. 1
figure1

a Axial CT of L4 (performed at a previous hospital) showed an osteolytic lesion around the left pedicle. The cortex was seen to be broken by the tumor. b T1 axial MRI of the L4 and L3/4 level with Gd enhancement. The left pedicle and its surrounding tissues show enhancement, while the tumor extends to the epidural space

We performed left side facetectomy and gross total resection of the tumor (Fig. 2a), and pathological diagnosis was OB without malignant features. The tumor was composed of irregular woven bone trabeculae. These woven bone trabeculae were lined with a single layer of osteoblasts with no conspicuous permeation to the surrounding bone. Osteoclast-type, multinucleated giant cells without atypia were present. Almost all of the tumor cells were p53-negative (Fig. 2b, c).

Fig. 2
figure2

a A resected specimen (3 cm × 3.5 cm) at the initial surgery. En-bloc excision was performed. b A low-power photomicrograph showing irregular trabeculae and prominent vessels. c A high-power photomicrograph showing irregular woven bone with osteoblastic rimming. No remarkable large, plump osteoblasts or atypical nuclei were observed, and many small blood vessels between the trabecular bones are seen with no atypia. The pathological findings did not support a diagnosis of osteosarcoma nor epithelioid osteoblastoma

Although her symptoms showed transient improvement, she complained of left side lumbar pain again at 4 months after surgery. CT and MRI showed local recurrence of the tumor (Fig. 3). Based on the radiological findings, we performed a second surgery. However, it was difficult to perform gross total resection of the tumor because of adhesion between the tumor and surrounding tissues. Histologically, the tumor showed the same features as the previous one: OB without malignant change.

Fig. 3
figure3

a Axial CT of L4 obtained at approximately 4 months after the initial surgery, at the recurrence of lumbago. Recurrence was suspected. b The same level on T2 axial MRI

At 3 months after the second surgery, the lumbar pain and pain of the left lower limb recurred. CT and MRI showed a recurrent tumor extending from the epidural space to the paravertebral area (Fig. 4a, b). We performed palliative resection of the tumor due to the worsening of lumbar pain and grade 4/5 muscle weakness. The pathological diagnosis was OB with no malignant change. Hematoma and mild fibrosis were also observed, suggesting ABC-like changes. There were no obvious features of telangiectatic osteosarcoma. CIRT (64 Gy [RBE] in 16 fractions) was performed over 4 weeks as an additional treatment for the residual lesion after the third surgery, because the tumor was locally aggressive. At 10 years after CIRT following multiple surgeries, MRI and X-ray showed neither tumor recurrence nor postoperative spinal deformity and the patient was ambulatory with slight muscle weakness of the left lower limb (Fig. 5a, b, c).

Fig. 4
figure4

a Axial CT of L4 obtained 3 months after the 2ndoperation. The region extended from the epidural space to the paravertebral area. b The same level on T2 axial MRI showed a fluid-fluid level containing lesion. Re-recurrence was suspected

Fig. 5
figure5

a X-ray and T2 axial MRI at 2 years after carbon ion radiotherapy. b The same level of T2 axial MRI 10 years later. No significant recurrence was observed

Discussion and conclusions

In the 2013 World Health Organization Classification of Tumor of Soft tissue and Bone, OB was classified as an intermediate (locally aggressive) osteogenic tumor [6]. At first, OB was reported as a benign osteogenic tumor with a similar histology to osteoid osteoma by Jaffe and Lichtenstein [1, 7]. In 1984, Dorfman and Weiss described some cases of osteoblastoma with infiltrative features and a high rate of recurrence; they referred to those tumors as aggressive OB [8]. Histologically, aggressive OB shows large, plump osteoblasts with prominent nucleoli, called epithelioid osteoblasts. There is no evidence that aggressive OB has a worse prognosis than the standard type of OB and it is debatable whether aggressive OB represents a distinct entity because of its local recurrence. Malignant change of OB was thought to be almost non-existent. These findings indicate that the tumors in cases in which malignant change of OB was reported might have actually been osteosarcoma from the beginning [9,10,11]. Although surgical treatment results in good outcomes without local recurrence in most cases of OB, the local recurrence rate of OBs after surgery has been reported to be approximately 15–20% [2]. Furthermore, tumors located near important tissues, including the central neural axis, nerve root and vertebral artery have a poor outcome after surgery, probably due to the difficulty associated with completing total resection [1, 2, 6, 12].

Recurrent tumors, especially those located near the spine, are very difficult to treat surgically [13, 14]. Thus, if the tumor has an aggressive nature, adjuvant chemotherapy and radiotherapy are considered after surgery, despite a lack of evidence to support this strategy [15, 16]. Yin et al. reported that the rate of recurrence in patients with aggressive OB was still as high as 60% after radiation therapy following total tumor resection [17]. Although there have been no reports on the effectiveness of CIRT for recurrent OB, CIRT shows great potential as a cure for X-ray-resistant tumors due to its ability to cause complex DNA double-strand breaks [4], and the effectiveness for sarcoma has been described elsewhere [18,19,20]. In the present case, CIRT was performed instead of conventional X-ray radiotherapy because recurrence developed after an extremely short interval, despite being histologically typical OB, and because it was considered to be a locally aggressive tumor that with aggressive clinical behavior that could not to be controlled by conventional radiation therapy.

The precise irradiation margin remains controversial, especially in the case of spinal tumors. According to previous studies, a margin of 5-mm is considered to provide safety from positioning errors and potential microscopic invasion, irrespective of the histology, and the potential area of spread [18, 19]. However, when the tumor is located close to critical organs, such as the spinal cord, the margin must be reduced accordingly [18]. In the present case, the tumor was close to the cauda equina. Since the dose constraint of the cauda equina is much higher than that of the spinal cord and CIRT can leave the unirradiated area of the cauda equina unirradiated, the coverage of the clinical target volume was prioritized over the dose of the cauda equina (Fig. 6).

Fig. 6
figure6

Dose distribution images of CIRT in the case. A total dose of 64.0 Gy (RBE) was applied to the tumor in 16 fractions over 4 weeks (the red line indicates a 90% isodose of the prescribed dose)

The subtypes and transformation of OB are still controversial [12, 21]. In the present case, recurrence was observed repeatedly in a short period after surgery, despite the gross total resection of the tumor in the initial surgery. However, all resected specimens showed the standard type of osteoblastoma, with no signs of malignancy (e.g., no marked nuclear pleomorphism or mitosis) and almost all tumor cells were p53-negative, which suggests osteosarcoma. Furthermore, there was no conspicuous proliferation of epithelioid osteoblasts suggestive of “epithelioid” OB with aggressive nature. Consequently, the addition of CIRT to treat the locally aggressive tumor after multiple surgeries achieved a good outcome.

In conclusion, the possibility of clinically aggressive behavior of OB should be taken into account, even when the histology is not consistent with malignancy or “epithelioid” OB. CIRT can be a treatment option for spinal OBs with a clinically aggressive nature, such as OB in cases with repeated recurrences soon after surgery.

Availability of data and materials

The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.

Abbreviations

OB:

Osteoblastoma

CIRT:

Carbon ion radiotherapy

CT:

Computed tomography

MRI:

Magnetic resonance imaging

Gy:

Gray

RBE:

Relative biological effectiveness

References

  1. 1.

    Lichtenstein L. Benign osteoblastoma: a category of osteoid-and bone-forming tumors other than classical osteoid osteoma, which may be mistaken for giant-cell tumor or osteogenic sarcoma. Cancer. 1956;9(5):1044–52.

  2. 2.

    Lucas DR, Unno KK, McLeod RA, et al. Osteoblastoma: clinicopathologic study of 306 cases. Hum Pathol. 1994;25(2):117–34.

  3. 3.

    Anne LV, Nicolas D, Stefano B, et al. Surgical management of spinal osteoblastomas. J Neurosurg Spine. 2017;27(3):321–7.

  4. 4.

    Oike T, Niimi N, Okonogi N, Murata K, Matsumura A, Noda S, Kobayashi D, Iwanaga M, Tsuchida K, Kanai T, Ohno T, Shibata A, Nakano T. Visualization of complex DNA double-strand breaks in a tumor treated with carbon ion radiotherapy. Sci Rep. 2016;6:22275.

  5. 5.

    Ando K, Kase Y. Biological characteristics of carbon-ion therapy. Int J Radiat Biol. 2009;85(9):715–28.

  6. 6.

    Andrea CE, Bridge JA, Schiller A. Osteoblastoma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. WHO Classification of Tumours of Soft Tissue and Bone. Lyon: IARC; 2013. p. 279–80.

  7. 7.

    Jaffe HL. Benign osteoblastoma. Bull Hosp Joint Dis. 1956;17(2):141–51.

  8. 8.

    Dorfman HD, Weiss SW. Borderline osteoblastic tumors: problems in the differential diagnosis of aggressive osteoblastoma and low-grade osteosarcoma. Semin Diagn Pathol. 1984;1(3):215–34.

  9. 9.

    Seki T, Fukuda H, Ishii Y, et al. Malignant transformation of benign osteoblastoma. A case report. J Bone Joint Surg Am. 1975;57(3):424–6.

  10. 10.

    Cerase A, Priolo F. Skeletal benign bone-forming lesions. Eur J Radiol. 1998;27(Suppl 1):S91–7.

  11. 11.

    Mitchell ML, Ackerman LV. Metastatic and pseudomalignant osteoblastoma: a report of two unusual cases. Skelet Radiol. 1986;15(3):213–8.

  12. 12.

    Lucas DR. Osteoblastoma. Arch Patrol Lab Med. 2010;134(10):1460–6.

  13. 13.

    Druschel C, Disch AC, Melcher I, et al. Surgical management of recurrent thoracolumbar spinal sarcoma with 4-level total en bloc spondylectomy: description of technique and report of two cases. Eur Spine J. 2012;21(1):1–9.

  14. 14.

    Boriani S, Bandiera S, Donthineni R, et al. Morbidity of en bloc resections in the spine. Eur Spine J. 2010;19(2):231–41.

  15. 15.

    Batay F, Savas A, Uğur HC, et al. Benign osteoblastoma of the orbital part of the frontal bone: case report. Acta Neurochir. 1998;140(7):729–30.

  16. 16.

    Li Z, Zhao Y, Hou S, et al. Clinical features and surgical management of spinal osteoblastoma: a retrospective study in 18 cases. PLoS One. 2013;8(9):e74635.

  17. 17.

    Yin H, Zhou W, Yu H, et al. Clinical characteristics and treatment options for two types of osteoblastoma in the mobile spine: a retrospective study of 32 cases and outcomes. Eur Spine J. 2014;23(2):411–6.

  18. 18.

    Matsumoto K, Imai R, Kamada T, et al. Impact of carbon ion radiotherapy for primary spinal sarcoma. Cancer. 2013;119(19):3496–503.

  19. 19.

    Imai R, Kamada T, Araki N, et al. Clinical efficacy of carbon ion radiotherapy for unresectable chondrosarcomas. Anticancer Res. 2017;37(12):6959–64.

  20. 20.

    Imai R, Kamada T, Araki N, et al. Carbon ion radiotherapy for unresectable localized axial soft tissue sarcoma. Cancer Med. 2018;7(9):4308–14.

  21. 21.

    Regina C, Cardim G, Oliveira M, et al. Clinical sciences classical osteoblastoma, atypical osteoblastoma, and osteosarcoma. A comparative study based on clinical, histological, and biological parameters. Clinics (Sao Paulo). 2007;62(2):167–74.

Download references

Acknowledgements

Not Applicable.

Funding

No funding was obtained for this study.

Author information

Affiliations

Authors

Contributions

AH designed and executed the experiments and wrote the manuscript. YI contributed to the whole concept and helped to write the manuscript. RI contributed to the treatment of carbon ion radiotherapy and helped to write the manuscript. JH and HK contributed to the concept of pathology and helped to write the manuscript. MN, TM, HS, SI, YK, and TT contributed to the concept and helped to write the manuscript. HC is a supervisor and edited the manuscript. All authors reviewed and approved the final manuscript.

Corresponding author

Correspondence to Akira Honda.

Ethics declarations

Ethics approval and consent to participate

This case report has been conducted according to the standards of the Declaration of Helsinki. Furthermore, this case was approved by the Institutional Ethics Committee of Hospital of the National Institute of Radiological Sciences, Quantum and Radiological Science and Technology.

Consent for publication

We confirm this information was obtained from the parent/guardian by written consent.

Competing interests

There are non-financial competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Honda, A., Iizuka, Y., Imai, R. et al. Recurrent lumbar-origin osteoblastoma treated with multiple surgery and carbon ion radiotherapy: a case report. BMC Musculoskelet Disord 21, 321 (2020). https://doi.org/10.1186/s12891-020-03349-4

Download citation

Keywords

  • Recurrent osteoblastoma
  • Multiple surgery
  • Carbon ion radiotherapy